COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,224 Articles (22,733 medRxiv, 8,491 bioRxiv)

Most recent first Previous |  Page 1429: Articles 14281-14290  | Next

Temporal changes in mental response and prevention patterns, and their impact from uncertainty stress during the transition in China from the COVID-19 epidemic to sporadic infection
Peng, S., Yang, X. Y., Yang, T., Zhang, W., Cottrell, R. R.
10.1101/2021.06.18.21259062 — Posted: 2021-06-23
Hybrid-Quantum approach for the optimal lockdown to stop the SARS-CoV-2 community spread subject to maximizing nation economy globally
Zaman, S., Khan, A., Sadhu, A., Das, D. K., Khan, F. S.
10.1101/2021.06.14.21258907 — Posted: 2021-06-23
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
Emmenegger, M., Kumar, S. S., Emmenegger, V., Buettner, T., Schierack, P., Sprinzl, M. F., Sommer, C., Lackner, K., Aguzzi, A., Roggenbuck, D., Frauenknecht, K. B. M.
10.1101/2021.06.21.449211 — Posted: 2021-06-23
I will teach you here or there, I will try to teach you anywhere: perceived supports and barriers for emergency remote teaching during COVID-19 pandemic
Donham, C., Barron, H. A., Alkhouri, J., Kumarath, M. C., Alejandro, W., Menke, E., Kranzfelder, P.
10.1101/2021.06.21.449058 — Posted: 2021-06-22
The Knowledge and Attitude of Physicians Regarding Vaccinations in Yerevan, Armenia: Challenges for COVID-19
Badalyan, A. R., Hovhannisyan, M., Ghavalyan, G., Ter-Stepanyan, M. M., Cave, R., Cole, J., Farlow, A. W. K., Mkrtchyan, H.
10.1101/2021.06.15.21258948 — Posted: 2021-06-22
Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system
Zhang, J. Z., Yeh, H.-W., Walls, A. C., Wicky, B. I., Sprouse, K., VanBlargan, L. A., Treger, R., Quijano-Rubio, A., Pham, M. N., Kraft, J. C., Haydon, I. C., Yang, W., DeWitt, M., Chow, C., Carter, L., Wener, M. H., Stewart, L., Veesler, D., Diamond, M., Baker, D.
10.1101/2021.06.22.449355 — Posted: 2021-06-22
Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation
Chen, H.-Y., Huang, C., Tian, L., Huang, X., Zhang, C., Llewellyn, G. N., Rogers, G. L., Andresen, K., O'Gorman, M. R. G., Chen, Y.-W., Cannon, P. M.
10.1101/2021.06.21.449352 — Posted: 2021-06-22
Breastfeeding mother-child clinical outcomes after COVID-19 vaccination
Low, J. M., Lee, L. Y., Ng, Y. P. M., Zhong, Y., Amin, Z.
10.1101/2021.06.19.21258892 — Posted: 2021-06-22
Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-April 2021
Gorelik, Y., Edelstein, M.
10.1101/2021.06.14.21258882 — Posted: 2021-06-22
A physically plausible incidence rate for compartmental epidemiological models
Pitschel, T.
10.1101/2021.06.19.21258779 — Posted: 2021-06-22 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).